SCHEMBL5507044

SCHEMBL5507044

O=C(CSc1ccc(C(=O)O)cc1)N[C@@H]1C(=O)N2C(C(=O)O)=C(C=C3CCN(Cc4ccc(O)cc4)C3=O)CS[C@H]12.[Na]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.46
NR1I2 O75469 1/20 0.45
MAPT P10636 4/20 0.44
TDP1 Q9NUW8 4/20 0.44
POLB P06746 2/20 0.44
PKM P14618 1/20 0.44
HTT P42858 1/20 0.44
DUSP3 P51452 1/20 0.44
PTPN5 P54829 1/20 0.44
PTPN11 Q06124 1/20 0.44
SPOP O43791 7/20 0.40
DRD2 P14416 1/20 0.40
PTGS2 P35354 1/20 0.40
DRD3 P35462 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP3A4 P08684 2/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5507026 0.99 CA5A (0.46) CA5ANR1I2MAPTTDP1POLB
SCHEMBL5507031 0.90 TDP1 (0.47) CA5ANR1I2MAPTTDP1POLB
SCHEMBL5504309 0.89 MAPT (0.47) CA5ANR1I2MAPTTDP1POLB
SCHEMBL5504305 0.88 MAPT (0.47) CA5ANR1I2MAPTTDP1POLB
SCHEMBL5503493 0.87 TDP1 (0.49) CA5ANR1I2MAPTTDP1POLB
SCHEMBL5503479 0.87 TDP1 (0.49) CA5ANR1I2MAPTTDP1POLB
Imidazole SCHEMBL5505088 0.87 CA5A (0.47) CA5ANR1I2MAPTTDP1POLB
Imidazole SCHEMBL5505092 0.87 CA5A (0.47) CA5ANR1I2MAPTTDP1POLB
SCHEMBL5501846 0.86 TDP1 (0.50) CA5ANR1I2MAPTTDP1POLB
SCHEMBL8708140 0.86 TDP1 (0.49) CA5ANR1I2MAPTTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841339-B1 Vinylpyrrolidinon cephalosporin derivatives BASILEA PHARMACEUTICA AG (CH) 2007-02-21 EP disclosed
US-6294668-B1 ANTIBACTERIAL ACTIVITY AGAINST BETA-LACTAM SENSITIVE AND RESISTANT GRAM-POSITIVE BACTERIA, SUCH AS STAPHYLOCOCCI, PNEUMOCOCCI, AND ENTEROCOCCI; USED IN THERAPY OF INFECTIOUS DISEASES CAUSED BY THOSE BACTERIA HOFFMAN-LA ROCHE INC. 2001-09-25 US disclosed
EP-0841339-A1 Vinylpyrrolidinon cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 1998-05-13 EP disclosed